Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2020 and February 4, 2020
Monthly information regarding the total number of voting rights and
total number of shares of the Company as of January 31, 2020 and February 4, 2020
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
01/31/2020 | 47,088,500 | Total gross of voting rights: 47,088,500 |
Total net* of voting rights: 47,047,250 |
Date | Total number of shares | Total number of voting rights |
04/02/2020 | 54,588,500 | Total gross of voting rights: 54,588,500 |
Total net* of voting rights: 54,551,798 |
* Total net = total number of voting rights attached to shares – shares without voting rights
Attachment
Upcoming Life Sciences Events
- April 2024
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum